Denosumab is a RANK ligand inhibitor used to treat osteoporosis and prevent fractures. It works by inhibiting osteoclast activity, reducing bone resorption. Denosumab is effective in managing bone health. In summary, Denosumab is beneficial for treating osteoporosis.
Denosumab binds to RANK ligand, inhibiting osteoclast formation and activity, thereby decreasing bone resorption.